Quoin Pharmaceuticals, Ltd. American Depositary Shares

QNRXNASDAQ • USD
3.85 USD
↗ 0.09 (2.26%)🟢LIVE (AS OF 10:05 AM EST)
🟢Market: OPEN

QNRX is currently priced at $3.85. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 11, 2026.

Open?$3.82
High?$3.99
Low?$3.79
Prev. Close?$3.76
Volume?3.6K
Avg. Volume?26.3K
VWAP?$3.89
Rel. Volume?0.13x
Bid / Ask
Bid?$3.25 × 100
Ask?$4.59 × 100
Spread?$1.34
Midpoint?$3.92
Valuation & Ratios
Market Cap?18.1M
Shares Out?3.1M
P/E Ratio?N/A
P/B Ratio?0.63
EPS?-$4.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
17.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-28
Address
42127 PLEASANT FOREST COURT
ASHBURN, VA 20148-7349
Phone: 703 980 4182
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.56Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?23.7K
Days to Cover?1.9
Avg Daily Volume12.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?7.20Strong
Quick Ratio?7.20Strong
Cash Ratio?2.11Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.63CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-68.3%WEAK▾
ROA?
S&P
3
-56.4%WEAK▾
Cash Flow & Enterprise
FCF?$-18817941
Enterprise Value?$8.0M
Fundamentals ratios updated end of day